Risk Factors for Ischemic Heart Disease.

BACKGROUND Several risk factors have been empirically linked to an increased risk of cardiovascular disease. Some of them are therapeutically amenable to modification; while others are not. Modifiable risk factors include physical inactivity, tobacco use, diet, "bad fats" in the blood, hypertension, and being overweight; while non-modifiable risk factors include the patient's family history, the presence versus absence of diabetes mellitus, and demographic characteristics like age, gender, ethnicity, and socio-economic status. METHODS In this article, we review those risk factors that are both clinically important and amenable to change. CONCLUSION To prevent cardiovascular disease, it is important to minimize modifiable risk factors, like LDL cholesterol.

• Publication year

  2019

• Venue

  Reviews on recent clinical trials

• Publication date

  2019-05-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1574887114666190328125153PMID 30919783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Homocysteine-lowering interventions for preventing cardiovascular events.

  2017cited by this paper
• Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.

  2016cited by this paper
• 2016 European Guidelines on cardiovascular disease prevention in clinical practice.

  2016cited by this paper
• Inflammation and Immunity in Diseases of the Arterial Tree: Players and Layers

  2015cited by this paper
• Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

  2015cited by this paper
• Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies: A Network Meta-Analysis

  2014cited by this paper
• 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

  2013cited by this paper
• Statin therapy for primary prevention of cardiovascular disease.

  2013cited by this paper
• Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality.

  2013cited by this paper
• 21st-century hazards of smoking and benefits of cessation in the United States.

  2013cited by this paper
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2012cited by this paper
• Standards of Medical Care in Diabetes—2013

  2012cited by this paper
• Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

  2012cited by this paper
• Nicotine replacement therapy for smoking cessation.

  2012cited by this paper
• C-reactive protein, fibrinogen, and cardiovascular disease prediction.

  2012cited by this paper
• Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies

  2012cited by this paper
• Improved Left Ventricular Mass Quantification With Partial Voxel Interpolation: In Vivo and Necropsy Validation of a Novel Cardiac MRI Segmentation Algorithm

  2012cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.

  2012cited by this paper
• The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

  2012cited by this paper
• Post-traumatic stress disorder is associated with poor health behaviors: findings from the heart and soul study.

  2012cited by this paper
• Lipid-related markers and cardiovascular disease prediction.

  2012cited by this paper
• Diabetes and hypertension: the bad companions.

  2012cited by this paper
• Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months

  2011cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

  2011cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials.

  2011cited by this paper
• Dose Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis

  2011cited by this paper
• Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk

  2010cited by this paper
• Body-mass index and mortality among 1.46 million white adults.

  2010cited by this paper
• Effects of combination lipid therapy in type 2 diabetes mellitus.

  2010cited by this paper
• Physical Activity and Cardiovascular Health: Lessons Learned From Epidemiological Studies Across Age, Gender, and Race/Ethnicity

  2010cited by this paper
• Lipoprotein(a) as a cardiovascular risk factor: current status

  2010cited by this paper
• Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

  2009cited by this paper
• Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies

  2007cited by this paper
• Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.

  2007cited by this paper
• Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999

  2006cited by this paper
• Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.

  2006cited by this paper
• Recommendations for chamber quantification.

  2006cited by this paper
• Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003).

  2006cited by this paper
• Age-Adjusted and Multivariate Odds Ratios of Sudden Cardiac Death and Nonsudden Cardiac Death According to Anxiety Symptoms Score Anxiety Symptom Score

  2005cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

  2003cited by this paper
• The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

  2003cited by this paper
• Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey

  2002cited by this paper
• Molecular Mechanisms of Human Hypertension

  2001cited by this paper
• Twins in Cardiovascular Genetic Research

  2001cited by this paper
• Function of C-reactive protein.

  2000cited by this paper
• Function of C-reactive protein

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

  2000cited by this paper
• Homocysteine and coronary heart disease: a review of the current evidence.

  1999cited by this paper
• Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

  1998cited by this paper
• Smoking and risk of myocardial infarction in women and men: longitudinal population study

  1998cited by this paper
• Inflammation, aspirin, and the risk of cardiovascular disease.

  1997cited by this paper
• Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence

  1997cited by this paper
• The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Symptoms of depression, acute myocardial infarction, and total mortality in a community sample.

  1996cited by this paper
• Heritability of conventional and ambulatory blood pressures. A study in twins.

  1995cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study.

  1994cited by this paper
• The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

  1994cited by this paper
• Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

  1993cited by this paper
• β-Cell Function in Relation to Islet Cell Antibodies During the First 3 Yr After Clinical Diagnosis of Diabetes in Type II Diabetic Patients

  1993cited by this paper
• Pathophysiology of obesity.

  1992cited by this paper
• Physical activity and 10.5 year mortality in the Multiple Risk Factor Intervention Trial (MRFIT).

  1991cited by this paper
• Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study.

  1991cited by this paper
• Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition.

  1990cited by this paper
• Frequency of uncomplicated angina pectoris in type A compared with type B persons (the Framingham Study).

  1989cited by this paper
• Precursors of essential hypertension: body weight, alcohol and salt use, and parental history of hypertension.

  1988cited by this paper
• A comparison of positive family history definitions for defining risk of future disease.

  1986cited by this paper
• Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study

  1983cited by this paper
• Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction.

  1982cited by this paper
• Left Ventricular Hypertrophy: Relationship of Anatomic, Echocardiographic and Electrocardiographic Findings

  1981cited by this paper

• Cardiovascular risk assessed using the SCORE system and blood renalase concentration in the Polish subpopulation of the PURE study

  2026cites this paper
• Multilevel obstacles to heart-healthy living in the context of Ischemic heart disease: A qualitative study

  2025cites this paper
• Global, regional, and national burden of early-onset ischemic heart disease: trends and projections among adults aged 15–44 years from 1990 to 2046

  2025cites this paper
• High Risk of Mild Cognitive Impairment in Elderly Patients with Cardiovascular Disease.

  2025cites this paper
• Risk factors of acute coronary syndrome among patients admitted to cardiac care units at governmental hospitals in the Gaza Strip: Case- control study

  2025cites this paper
• Using Big Data to Predict Young Adult Ischemic vs. Non-Ischemic Heart Disease Risk Factors: An Artificial intelligence Based Model

  2025cites this paper
• The financial consequences of undiagnosed memory disorders

  2024cites this paper
• Assessment of Carotid Plaque Enhancement on Contrast-Enhanced Ultrasound as a Predictor for Severe Coronary Artery Disease

  2024cites this paper
• Risk of Ischemic Heart Disease in Patients With Postpancreatectomy Diabetes and Pancreatic Cancer: A Population‐Based Study

  2023cites this paper
• Coexistence of Cardiovascular Risk Factors and Blood Renalase Concentration

  2023cites this paper
• Obezite Polikliniğine Başvuran Hastalarda Hematolojik ve Biyokimyasal Parametrelerle Kardiyovasküler Risk Skorlarının Karşılaştırılması

  2022cites this paper
• Myosin 1b Participated in the Modulation of Hypoxia/Reoxygenation-Caused H9c2 Cell Apoptosis and Autophagy

  2022cites this paper
• The efficacy and safety of Rhodiola formulation for the treatment of ischemic heart disease: A protocol for systematic review and meta-analysis

  2022cites this paper
• CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases.

  2022cites this paper
• Risk of Ischemic Heart Disease Associated with Primary Dysmenorrhea: A Population-Based Retrospective Cohort Study

  2022cites this paper
• Coexistence of cardiovascular risk factors and obstructive sleep apnoea in polysomnography.

  2021cites this paper
• Systematic Analysis of the Global, Regional and National Burden of Cardiovascular Diseases from 1990 to 2017

  2021cites this paper
• Modifiable and Non-modifiable Risk Factors in Myocardial Infarction in the Iranian Population

  2020cites this paper